Higher dosing of temozolomide? Regression of an anaplastic oligoastrocytoma over more than three years [1]

Journal of Neuro-Oncology

Volumn 77, Issue 2, 2006, Pages 219-220

  Koch, Dorothee ^a   Wick, Wolfgang ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

ADULT; BONE MARROW SUPPRESSION; BRAIN CONCUSSION; BRAIN EDEMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER SURGERY; CASE REPORT; CONTRAST ENHANCEMENT; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG RESPONSE; FALLING; GLIOBLASTOMA; HEADACHE; HUMAN; IMAGE ANALYSIS; LETTER; LEUKOPENIA; MALE; MEDICATION ERROR; MULTIPLE DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT DECISION MAKING; PHYSICIAN; RECURRENT CANCER; THROMBOCYTOPENIA; TRAFFIC ACCIDENT; ASTROCYTOMA; BONE MARROW; BRAIN TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INTOXICATION; MIDDLE AGED;

ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BONE MARROW; BRAIN NEOPLASMS; DACARBAZINE; HUMANS; LEUKOPENIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OVERDOSE; THROMBOCYTOPENIA;

EID: 33747822102     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9019-7     Document Type: Letter

References (5)

1. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA, A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83: 588-593, 2000
2. Wick W, Steinbach JP, Küker W, Dichgans J, Weller M, One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma Neurology 62: 2113-2115, 2004
3. Wick W, Weller M, How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience J Clin Oncol 23: 4235-4236, 2005
4. Stupp R, Mason WP, Van den Bent M, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes AA, Cairncross JG, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin S, Gorlia T, Allgeier A, Lacombe D, Eisenhauer E, Mirimanoff RO, On behalf of the European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma N Engl J Med 352: 997-1003, 2005
5. MacDonald DR, Cascino TL, Schold SC, Cairncross JG, Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8: 1277-1280, 1990